High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance).

ABSTRACT:

SUBMITTER: Witzig TE 

PROVIDER: S-EPMC5520404 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature